A new publication from Opto-Electronic Technology; DOI 10.29026/oet.2026.250009, discusses progress and applications of ...
Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that ...
A new publication from Opto-Electronic Technology; DOI 10.29026/oet.2026.250009 , discusses progress and applications of terahertz imagining ...
Neurocrine Biosciences is in advanced talks to acquire Soleno Therapeutics for just over $2.5 billion, or low-to-mid $50s per ...
PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat populationPhase 1b data demonstrate endoscopic improvement ...
This strategic partnership with WuXi XDC represents a major milestone for Akari and a powerful validation of our novel PH1 ...
Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
A light pulse is technically empty, yet capable of carrying a trillion photons in a single burst. That is part of what makes ...
Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) Q4 2025 Earnings Call Transcript March 30, 2026 Operator: Good day, and thank you for standing by. Welcome to the Bicara Therapeutics Fourth Quarter ...
This magnetic induction technology quietly opens possibilities for communication in extreme environments, where traditional ...
Hans-Gerd Janssen reflects on the importance of the Riva Conference conference to advance his expertise in separation science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results